Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
161 Cards in this Set
- Front
- Back
Antipsychotic which has rare (1-2%) incidence of agranulocytosis and requires weekly CBC
|
Clozapine
|
|
Common antipsychotic to cause tardive dyskinesia
|
Haloperidol
|
|
Drug class of risperidone
|
2nd generation antipsychotic
|
|
SSRI more sedating than others, useful for PTSD
|
Paroxetine
|
|
What is Frotteurism
|
Sexual arousal obtained by rubbing up against a person who is unaware of the activity
|
|
Reason for hypovolemia in pt taking lithium
|
Nephrogenic diabetes insipidus
|
|
DOC for absence seizure
|
Valproic acid
|
|
Alternate name for absence seizure
|
Petit mal
|
|
MOA of benzos
|
Increase frequency of GABA chloride channel opening
|
|
Night terrors and sleepwalking occur during what sleep stage?
|
3 and 4
|
|
Anti-seizure drug causing agranulocytosis in a small number of people
|
Carbamazepine
|
|
Typical antipsychotic agent with 0.5% incidence of agranulocytosis
|
Clozapine
|
|
Food craving in seasonal affective disorder
|
Carbohydrates
|
|
Given for severe symptoms of PCP intoxication
|
Benzodiazepines
|
|
Presenting symptoms of psychogenic polydipsia
|
Delirium and/or serizures
|
|
Difference between bipolar I and II
|
I has mania, II has hypomania
|
|
Drug class for prevention of panic attacks
|
SSRI's
|
|
Pediatric form of anti-social personality
|
Conduct disorder
|
|
Effect on alcohol on CYP 450
|
Decreased acutely, increases with chronic use
|
|
Effect of phenytoin on CYP 450
|
Induced
|
|
Describe schizoid personality disorder
|
Lack of close relationships, minimal interest is sex/activities, emotional detachment
|
|
Define: alogia
|
Absence of speech
|
|
Main sign of schizotypal personality disorder
|
Bizarre/odd/eccentric behavior - often socially isolated because of it
|
|
Define confabulation
|
Formation of false memories to cover up loss of real ones
|
|
Seen in delirium tremens but not in Korsakoff psychosis
|
Delirium and/or seizures
|
|
Difference between Korsakoff syndrome and Korsakoff psychosis
|
Syndrome has the mamillary body lesions, psychosis does not
|
|
Three symptoms of Korsakoff psychosis
|
Amensia, hallucinations, confabulation
|
|
Action and use of methylphenidate
|
CNS stimulant; ADHD (Ritalin)
|
|
Lesion in what part of brain will cause disinhibition and acting on sexual urges?
|
Amygdala
|
|
Phenelzine is what type of drug?
|
MAO inhibitor
|
|
Psych dx for pt with numberous complaints in several organ systems with no obvious cause
|
Somatization disorder
|
|
Generic name for valium
|
Diazepam
|
|
SSRI with greater effect on norepinephrine than serotonin
|
Duloxetine
|
|
List the DSM-IV axes
|
Axis I - Current psych diagnosis
Axis II - Personality disorder Axis III - All non-psych medical disorders Axis IV - Psychosocial Axis V - Global Axis of Functioning (GAF) |
|
Drug class of isocarboxazid
|
MAO inhibitor
|
|
Name 3 MAO inhibitors
|
Isocarboxazid, Phenelzine, Tranylcypromine
|
|
Food content avoided in MAO inhibitors
|
Tyramine
|
|
Consequence of MAO inhibitor + tyramine
|
Hypertensive crisis
|
|
Personality disorder often displaying interest in magic, extra-sensory perception, etc
|
Schizotypal
|
|
Cluster A personality disorders
|
"Always After me, Apathetic, and Awkward" = Paranoid, schizoid, schizotypal
|
|
Cluster B personality disorders
|
"Bitches and Bastards" = Antisocial, borderline, histrionic, narcissistic
|
|
Cluster C personality disorders
|
"Coy, Clingy, and Compulsive" = Avoidant, dependent, obsessive-compulsive
|
|
Time criteria for brief psychotic, schizophreniform, paranoid schizophrenia
|
Brief = > 1 month, Schizophreniform = 1-6 months, Schizophrenia = > 6 months
|
|
Personality disorder with identity disturbance, impulsivity, suicidal behavior
|
Borderline
|
|
What is schizoaffective disorder
|
Psychotic symptoms + depressive, manic, or mixed episode
|
|
Personality type that is looking to please everyone
|
Avoidant (people pleasers due to fear of being disliked)
|
|
Anti-seizure drug causing SIADH/hyponatremia
|
Carbamazepine
|
|
Effect of valproic acid on CYP450
|
Inhibits
|
|
Type of seizure lamotrigine treats
|
Partial
|
|
MOA of lithium
|
Blocks actions of cAMP and IP-3
|
|
Tx for TCA overdose
|
Sodium bicarbonate
|
|
Common side effect of hypnotic agents
|
Sedation
|
|
Occurs when sedative hypnotics are used chronically or at high doses
|
Tolerance
|
|
The most common type of drug interaction of sedative hypnotics with other depressant medications
|
Additive CNS depression
|
|
Benzodiazepines used to promote sleep
|
Temazpam, trizolam, flurazepam
|
|
Benzodiazepine used for acute anxiety
|
Alprazolam
|
|
Non-benzodiazepine used as an anxiolytic
|
Buspirone
|
|
Non-benzodiazepine used for sleep
|
Zolpidem
|
|
Major effect of benzodiazepines on sleep at high doses
|
REM is decreased
|
|
Neurologic SE of benzodiazepines
|
Anterograde amnesia
|
|
Reason benzos are used cautiously in pregnancy
|
Ability to cross the placenta
|
|
Main route of metabolism for benzodiazepines
|
Hepatic
|
|
Benzodiazepine that undergo extrahepatic conjugation (which are useful in older or hepatically impaired)
|
Lorazepam, oxazepam, and temazepam
|
|
MOA for benzodiazepines
|
increase the FREQUENCY of GABA-mediated chloride ion channel opening
|
|
Antidote to benzodiazepine overdose (antagonist that reverses the CNS effects)
|
Flumazenil
|
|
Benzodiazepine with useful relaxant effects in skeletal muscle spasticity of central origin
|
Diazepam
|
|
Benzodiazepine that has efficacy against absence seizures and in anxiety states, such as agoraphobia
|
Clonazepam
|
|
Benzodiazepines that are the most effective in the treatment of panic disorder
|
Alprazolam and Clonazepam
|
|
Benzodiazepine that is used for anesthesia
|
Midazolam
|
|
Benzo used for status epilepticus
|
Diazepam
|
|
Longer acting benzodiazepines used in the management of withdrawal states of alcohol and other drugs
|
Chlordiazepoxide and Diazepam
|
|
Rate limiting step of alcohol metabolism
|
Aldehyde dehydrogenase
|
|
System that increases in activity with chronic ethanol exposure and may contribute to tolerance
|
MEOS
|
|
Enzyme that metabolizes acetaldehyde to acetate
|
Aldehyde dehydrogenase
|
|
Agents that inhibit acetaldehyde dehydrogenase
|
Disulfiram, metronidazole, certain sulfonylureas and cephalosporins
|
|
Agent that inhibits alcohol dyhydrogenase and its clinical use
|
FOMEPIZOLE – used to prevent formation of toxic metabolites from methanol and ethylene glycol ingestion
|
|
Agent used in the treatment of alcoholism, if alcohol is consumed concurrently, acetaldehyde builds up and results in nausea, headache, flushing, and hypotension
|
Disulfiram
|
|
The most common neurologic abnormality in chronic alcoholics
|
Peripheral neuropathy (also excessive alcohol use is associated with HTN, anemia, and MI)
|
|
Agent that is the antidote for methanol overdose
|
Ethanol, fomepizole
|
|
Drug that inhibits alcohol dehydrogenase and is used in ethylene glycol exposure
|
Fomepizole
|
|
Most frequent route of metabolism for anti-seizure meds
|
Hepatic enzymes
|
|
Mechanisms of action for Phenytoin, Carbamazepine, Lamotrigine
|
Sodium channel blockade
|
|
Target receptor for benzodiazepines and barbiturates
|
GABA
|
|
MOA for Ethosuximide
|
Calcium channels
|
|
MOA for Valproic acid at high doses
|
Affect calcium, potassium, and sodium channels
|
|
Drugs of choice for generalized tonic-clonic and partial seizures
|
Valproic acid and Phenytoin
|
|
DOC for febrile seizures
|
Phenobarbital
|
|
Drugs of choice for absence seizures
|
Ethosuximide and valproic acid
|
|
Drug of choice for myoclonic seizures
|
Valproic acid
|
|
Drugs of choice for status epilepticus
|
IV diazepam for short term (acute) treatment; phenytoin for prolonged therapy
|
|
Drugs that can be used for infantile spasms
|
Corticosteroids
|
|
Anti-seizure drugs used also for Trigeminal neuralgia
|
Carbamazepine
|
|
Anti-seizure drugs used also for pain of neuropathic orgin
|
Gabapentin
|
|
Anti-seizure agent that exhibits non-linear metabolism, highly protein bound, causes fetal hydantoin syndrome, and stimulates hepatic metabolism
|
Phenytoin
|
|
SE of phenytoin
|
Gingival hyperplasia, nystagmus, diplopia and ataxia
|
|
Anti-seizure agent that induces formation of liver drug-metabolism enzymes, is teratogen and can cause craniofacial anomalies and spina bifida
|
Carbamazepine
|
|
Anti-seizure agent that inhibits hepatic metabolism, is hepatotoxic and teratogen that can cause neural tube defects and gastrointestinal distress
|
Valproic acid
|
|
Laboratory value required to be monitored for patients on valproic acid
|
Serum ammonia and LFT's
|
|
SE for Lamotrigine
|
Stevens-Johnson syndrome
|
|
SE for Felbamate
|
Aplastic anemia and acute hepatic failure
|
|
Anti-seizure medication also used in the prevention of migraines
|
Valproic acid
|
|
Carbamazepine may cause
|
Agranulocytosis
|
|
Anti-seizure drugs used for mood stabilization (bipolar)
|
Carbamazepine, gabapentin, lamotrigine, and valproic acid
|
|
MOA of neuroleptics
|
Dopamine blockade
|
|
Side effects occuring in antipsychotics that block dopamine
|
Hyperprolactinemia, menorrhea, galactorrhea, confusion, mood changes, decreased sexual interest, and weight gain
|
|
Antipsychotics that reduce positive symptoms only
|
Older antipsychotics
|
|
Newer atypical antipsychotics that also improve some of the negative symptoms and help acute agitation
|
Olanzapine, aripiprazole, and sertindole
|
|
Antipsychotic used in the treatment of psychiatric symptoms in patients with dementia
|
Risperidone
|
|
Atypical antipsychotic causing high prolactin levels
|
Risperidone
|
|
Newer atypical antipsychotic used for bipolar disorder, known to cause weight gain, and adversely affect diabetes
|
Olanzapine
|
|
Agent more frequently associated with extrapyramidal side effects that can be treated with benzodiazepine, diphenhydramine or muscarinic blocker
|
Haloperidol
|
|
Drug used in neuroleptic malignant syndrome
|
Dantrolene
|
|
Agents may exacerbate tardive dyskinesias (may be irreversible and there is no treatment)
|
Muscarinic blockers
|
|
Antipsychotic having the strongest autonomic effects
|
Thioridazine
|
|
Antipsychotic having the weakest autonomic effects
|
Haloperidol
|
|
Only phenothiazine not exerting antiemetic effects, can cause visual impairment due to retinal deposits, and high doses have been associated with ventricular arrhythmias
|
Thioridazine
|
|
Agent having no effect on D2 receptors, blocks D4, reserved for resistant schizophrenia, and can cause fatal agranulocytosis
|
Clozapine
|
|
Anti-psychotic not shown to cause tardive dyskinesia
|
Clozapine
|
|
Anti-psychotics available in depot preparation
|
Fluphenazine and haloperidol
|
|
Antipsychotics with Reduced seizure threshold
|
Low-potency typical antipsychotics and clozapine
|
|
Antipsychotic with Orthostatic hypotension and QT prolongation
|
Low potency phenothiazines and ziprasidone
|
|
Antipsychotic with Increased risk of developing cataracts
|
Quetiapine
|
|
Major route of elimination for Lithium
|
Kidneys
|
|
Patients being treated with lithium, who are dehydrated, or taking diuretics concurrently, could develop
|
Lithium toxicity
|
|
Drug increases the renal clearance hence decreases levels of lithium
|
Theophylline
|
|
Lithium is associated with this congenital defect
|
Cardiac anomalies
|
|
DOC for bipolar affective disorder
|
Lithium
|
|
SE of lithium
|
Tremor, sedation, ataxia, aphasia, thyroid enlargement, and reversible diabetes insipidus
|
|
Example of three antidepressants that are indicated for obsessive compulsive disorder
|
Clomipramine, fluoxetine and fluvoxamine
|
|
Neurotransmitters affected by the action of antidepressants
|
Norepinephrine and serotonin
|
|
How long one-liners and case files says antidepressents take to work
|
2 to 3 weeks
|
|
Population group especially sensitive to side effects of antidepressants
|
Elderly patients
|
|
All antidepressants have roughly the same efficacy in treating depression, agents are chosen based on these criterion
|
Side-effect profile and prior pt response
|
|
Well-tolerated and are first-line antidepressants
|
SSRI's, bupropion, and venlafaxine
|
|
Most useful in patients with significant anxiety, phobic features, hypochondriasis, and resistant depression
|
Monamine oxidase inhibitors
|
|
Condition will result from in combination of MAOI with tyramine containing foods (ex. wine, cheese, and pickled meats)
|
Hypertensive crisis
|
|
MAOI should not be administered with SSRI's or potent TCA's due to development of this condition
|
Serotonin syndrome
|
|
Sedation is a common side effect of these drugs, they lower seizure threshold, uses include BAD, acute panic attacks, phobias, enuresis, and chronic pain and their overdose can be deadly
|
Tricyclic antidepressants (TCA)
|
|
Three C's associated with TCA toxicity
|
Coma, Convulsions, Cardiac problems (arrhythmias and wide QRS)
|
|
Agents having higher sedation and antimuscarinic effects than other TCA's
|
Tertiary amines
|
|
TCA used in chronic pain, a hypnotic, and has marked antimuscarinic effects
|
Amitriptyline
|
|
TCA used in chronic pain, enuresis, and ADD
|
Imipramine
|
|
TCA with greatest sedation and marked antimuscarinic effects, used for sleep
|
Doxepin
|
|
TCA used in obsessive compulsive disorder (OCD), most significant of TCA's for risk of seizure, weight gain, and neuropsychiatric signs and symptoms
|
Clomipramine
|
|
Secondary amines that have less sedation and more excitation effect
|
Nortriptyline, Desipramine
|
|
Side effects seen with tricyclic antidepressants
|
Muscarinic blockade (dry mouth, constipation); weak alpha-1 block (orthostatic hypotension); weak hisamine block (sedation)
|
|
Antidepressant associated with neuroleptic malignant syndrome
|
Amoxapine
|
|
Antidepressant associated with seizures and cardiotoxicity
|
Maprotiline
|
|
Antidepressant having stimulant effects similar to SSRI's and can increase blood pressure
|
Venlafaxine
|
|
Antidepressant inhibiting norepinephrine, serotonin, and dopamine reuptake
|
Venlafaxine
|
|
Antidepressant also used for sleep that causes priapism
|
Trazodone
|
|
Antidepressant which is inhibitor of CYP450 enzymes and may be associated with hepatic failure
|
Nefazodone
|
|
Heterocyclic antidepressants least likely to affect sexual performance, used for management of nicotine withdrawal, SE's include dizziness, dry mouth, aggravation of psychosis, and seizures
|
Bupropion
|
|
Antidepressant with MOA as alpha 2 antagonist, has effects on both 5-HT and NE, blocks histamine receptors, and is sedating
|
Mirtazapine
|
|
SE of mirtazapine
|
Liver toxicity, increased serum cholesterol
|
|
Except for these agents all SSRI have significant inhibition of CytP450 enzymes
|
Citalopram and its metabolite escitalopram
|
|
Antidepressants with no effect on BP, no sedation
|
SSRIs
|
|
SSRI with long T1/2 and can be administered once weekly for maintenance, not acute tx
|
Fluoxetine
|
|
SSRI indicated for premenstrual dysphoric disorder
|
Fluoxetine (Sarafem)
|
|
Some of SSRIs' therapeutic effects beside depression
|
Panic attacks, social phobias, bulimia nervosa, and PMDD (premenstrual dysphoric disorder), OCD
|
|
SSRI less likely to cause a withdrawal syndrome
|
Fluoxetine
|